Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer … (NCT07083518) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors
China60 participantsStarted 2025-05-29
Plain-language summary
This study aims to evaluate the efficacy of transcranial direct current stimulation (tDCS) in improving cancer-related cognitive impairment (CRCI) in breast cancer survivors. Participants will be randomly assigned to receive active or sham stimulation over the prefrontal cortex. Cognitive outcomes will be assessed using standardized neuropsychological tests and self-reported measures. Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) will be used to explore neural correlates of intervention effects.
Who can participate
Age range18 Years – 65 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Female breast cancer survivors aged 18-65 years.
✓. Initially diagnosed with stage I-III non-metastatic breast cancer.
✓. Between 6 months and 5 years after completion of initial curative surgery +/- radiation/chemotherapy.
✓. allowed to be on endocrine therapy and/or anti-HER2 targeted therapy.
✓. Self-reported cognitive complaints following cancer treatment.